课题基金 / 基金详情

OASIS, a CREB/ATF-family transcription factor, modulate transcription of C6ST1 gene and chondroitin sulfation

OASIS, a CREB/ATF-family transcription factor, modulate transcription of C6ST1 gene and chondroitin sulfation
OASIS 是一种 CREB/ATF 家族转录因子,调节 C6ST1 基因的转录和软骨素硫酸化
批准号:
22791353
负责人:
OKUDA Hiroaki
金额:
$2.58万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2011
关键词:

项目摘要

项目成果

OKUDA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
在中枢神经系统中,内质网应激与包括缺血性损伤和神经退行性疾病在内的一系列疾病有关。损伤皮质中OASIS的mRNA和蛋白水平均升高,且与反应性星形胶质细胞的表达密切相关。反应性星形胶质细胞是胶质瘢痕的主要细胞成分,包裹在病变部位,并产生抗再生分子,如硫酸软骨素蛋白多糖(CSPGs)。我们利用OASIS基因敲除小鼠分析了CS-糖胺聚糖合成酶的mRNA水平。软骨素6-磺基转移酶1(C6ST1)在野生型小鼠皮质损伤中表达增加,而在绿洲基因敲除小鼠中不表达。此外,OASIS结合第一内含子区域并促进C6ST1的转录。这些结果表明,OASIS可能通过转录C6ST1参与星形胶质细胞CSPG的产生。
英文摘要
In the central nerve system, ER stress is implicated in a wide range of disorders including ischemic injury and neurodegenerative disorder. Both mRNA and protein levels of OASIS were elevated in the injured cortex and correlated closely with those of reactive astrocyte. Reactive astrocyte, which constitute a major cellular component of glial scar, enmesh the lesion site and produce anti-regenerative molecules such as chondroitin sulphate proteoglycans(CSPGs). We have analyzed the mRNA levels of the CS-glycosaminoglycan synthesizing enzymes using OASIS knockout mice. Expression of chondroitin 6-sulfotransferase 1(C6ST1) is increased in cortical stub injury in wild type mice, but is not in OASIS knock out mice. Furthermore, OASIS bound to the first intron region and promoted transcription of C6ST1.These results suggest that OASIS may be involved in CSPG production through the transcription of C6ST1 in astrocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of DACS, novel matrix structure composed of chondroitin sulfate proteoglycan in the brain
  • 批准号:
    24592141
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2012
  • 负责人:
    OKUDA Hiroaki
  • 依托单位:
Development of a monoclonal antibody to PIVKA-IX, PIVKA-X and study on the mechanism of production of PIVKA by hepatocellular carcinoma
  • 批准号:
    02670325
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.15万
  • 财政年份:
    1990
  • 负责人:
    OKUDA Hiroaki
  • 依托单位:
Clinical and Experimental Study of Production of Abnormal Prothrombin PIVKA-II in Hepatocellular Carcinoma.
  • 批准号:
    62570337
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 资助金额:
    $1.34万
  • 财政年份:
    1987
  • 负责人:
    OKUDA Hiroaki
  • 依托单位:
海外基金